Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02485652
Title Phase II Trial of HM61713 for the Treatment of >= 2nd Line T790M Mutation Positive Adenocarcinoma of the Lung
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hanmi Pharmaceutical Company Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU | CAN | AUS

Facility Status City State Zip Country Details
Research Site Beverly Hills California United States Details
Research Site Burbank California United States Details
Research Site 2 Los Angeles California United States Details
Research Site Los Angeles California United States Details
Research Site Montebello California United States Details
Research Site Orange California United States Details
Research Site San Diego California United States Details
Research Site Boca Raton Florida United States Details
Research Site Honolulu Hawaii United States Details
Research Site Evanston Illinois United States Details
Research Site Bethesda Maryland United States Details
Research Site Boston Massachusetts United States Details
Research Site Lebanon New Hampshire United States Details
Research Site Charlotte North Carolina United States Details
Research Site Washington Washington United States Details
Research Site Darlinghurst Australia Details
Research site Fitzroy Australia Details
Research Site Frankston Australia Details
Research Site Kogarah Australia Details
Research Site St Albans Australia Details
Research Site Woolloongabba Australia Details
Research Site Toronto Canada Details
Research Site Berlin Germany Details
Research Site Homburg Germany Details
Research Site Leipzig Germany Details
Research Site München Germany Details
Research Site Ulm Germany Details
Research Site Bergamo Italy Details
Research Site Bologna Italy Details
Research Site Catania Italy Details
Research Site Milano Italy Details
Research Site Rome Italy Details
Research Site Cheongju-si Korea, Republic of Details
Research Site Goyang-si Korea, Republic of Details
Research Site Hwasun Korea, Republic of Details
Research Site Incheon Korea, Republic of Details
Research Site 2 Seongnam-si Korea, Republic of Details
Research Site Seongnam-si Korea, Republic of Details
Research Site 2 Seoul Korea, Republic of Details
Research Site 3 Seoul Korea, Republic of Details
Research Site 4 Seoul Korea, Republic of Details
Research Site 5 Seoul Korea, Republic of Details
Research Site 6 Seoul Korea, Republic of Details
Research Site 7 Seoul Korea, Republic of Details
Research Site 8 Seoul Korea, Republic of Details
Research Site Seoul Korea, Republic of Details
Research Site George Town Penang Malaysia Details
Research Site Kuala Lumpur Malaysia Details
Research Site Kuantan Malaysia Details
Research Site Kuching Malaysia Details
Research Site Makati Kalakhang Maynila Philippines Details
Research Site Pasig Manila Philippines Details
Research Site 2 Manila Metro Manila Philippines Details
Research Site Manila Metro Manila Philippines Details
Research Site Cebu Philippines Details
Research Site 2 Barcelona Spain Details
Research Site 3 Barcelona Spain Details
Research Site 4 Barcelona Spain Details
Research Site Barcelona Spain Details
Research Site La Coruna Spain Details
Research Site 2 Madrid Spain Details
Research Site Madrid Spain Details
Research Site Navarra Spain Details
Research Site San Sebastian Spain Details
Research Site 2 Valencia Spain Details
Research Site Valencia Spain Details
Research Site Kaohsiung Taiwan Details
Research Site Taichung Taiwan Details
Research Site 2 Tainan Taiwan Details
Research Site Tainan Taiwan Details
Research Site 2 Taipei Taiwan Details
Research Site Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field